Rubicon Organics Inc. (ROMJ.V)
CAD 0.4
(-1.25%)
CAD 0.4
(-1.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.08 Million CAD | 58.15% |
| 2022 | -2.58 Million CAD | 80.47% |
| 2021 | -13.25 Million CAD | -10.57% |
| 2020 | -11.98 Million CAD | -24.5% |
| 2019 | -9.63 Million CAD | 27.96% |
| 2018 | -13.36 Million CAD | -138.42% |
| 2017 | -5.6 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.66 Million CAD | 102.74% |
| 2024 Q1 | -4.33 Million CAD | -68.81% |
| 2023 Q4 | -2.56 Million CAD | -70.25% |
| 2023 Q2 | -160.39 Thousand CAD | 47.32% |
| 2023 FY | -12.37 Million CAD | -378.21% |
| 2023 Q1 | -304.49 Thousand CAD | 88.79% |
| 2023 Q3 | -1.5 Million CAD | -840.0% |
| 2022 Q2 | -943.96 Thousand CAD | 16.41% |
| 2022 Q3 | 2.2 Million CAD | 333.27% |
| 2022 FY | -2.58 Million CAD | 80.47% |
| 2022 Q1 | -1.12 Million CAD | 17.52% |
| 2022 Q4 | -2.71 Million CAD | -223.41% |
| 2021 FY | -13.25 Million CAD | -10.57% |
| 2021 Q4 | -1.36 Million CAD | 62.17% |
| 2021 Q3 | -3.61 Million CAD | 26.39% |
| 2021 Q2 | -4.91 Million CAD | -46.56% |
| 2021 Q1 | -3.35 Million CAD | 22.23% |
| 2020 Q3 | -3.61 Million CAD | -322.76% |
| 2020 Q2 | -854.51 Thousand CAD | 73.38% |
| 2020 FY | -11.98 Million CAD | -24.5% |
| 2020 Q1 | -3.21 Million CAD | -606.87% |
| 2020 Q4 | -4.31 Million CAD | -19.38% |
| 2019 FY | -9.63 Million CAD | 27.96% |
| 2019 Q4 | -454.13 Thousand CAD | 88.15% |
| 2019 Q3 | -3.83 Million CAD | -17.85% |
| 2019 Q2 | -3.25 Million CAD | -55.47% |
| 2019 Q1 | -2.09 Million CAD | 55.82% |
| 2018 Q4 | -4.73 Million CAD | -30.07% |
| 2018 FY | -13.36 Million CAD | -138.42% |
| 2018 Q1 | -2.32 Million CAD | -50.72% |
| 2018 Q2 | -1.54 Million CAD | 33.74% |
| 2018 Q3 | -3.63 Million CAD | -136.17% |
| 2017 FY | -5.6 Million CAD | 0.0% |
| 2017 Q4 | -1.54 Million CAD | -28.62% |
| 2017 Q3 | -1.2 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.82 Million CAD | 61.584% |
| CanadaBis Capital Inc. | 4.67 Million CAD | 123.166% |
| Decibel Cannabis Company Inc. | 1.41 Million CAD | 176.731% |
| Delivra Health Brands Inc. | -710 Thousand CAD | -52.598% |
| Entourage Health Corp. | -21.37 Million CAD | 94.932% |
| Lifeist Wellness Inc. | -12.24 Million CAD | 91.156% |
| Cannara Biotech Inc. | 11.88 Million CAD | 109.114% |
| Medicure Inc. | -854 Thousand CAD | -26.867% |
| PharmaCielo Ltd. | -9.7 Million CAD | 88.832% |
| BioSyent Inc. | 7.47 Million CAD | 114.502% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 11.262% |